Tag Archives: good-news

Study: Limiting opioid Rx won’t reduce overdose deaths

Limiting opioid prescriptions will do little to reduce overdose deaths, study says – by Felice J. Freyer Globe Staff  February 01, 2019

This article is about a very important, and for us very encouraging, new JAMA study that just came out showing that prescription limits barely reduce overdoses. We pain patients have known this all along, but when it’s officially researched and published it will be taken more seriously.

The anti-opioid zealots will try to explain away its findings, but it will be a piece of hard evidence that saner minds can use to push back against these ridiculously ineffective prescription opioid limits.

When the death toll from opioid overdoses began to soar a few years ago… Policy makers naturally sought to put a lid on opioid prescribing.

But a study published Friday in JAMA Network Open finds that reducing opioid prescriptions will have little effect on the death rate over the next few years, now that the epidemic is dominated by heroin and illicit fentanyl.   Continue reading

The Other Side of Opioids – YouTube

The Other Side of Opioids – YouTube

Here is a mainstream media outlet that’s bucking the opioid BS trend and reporting the truth about our desperate situation – which has nothing to do with the rising rates of overdose deaths from opioids or anything else people can get their hands on.

LAS VEGAS – Nightly newscasts across the country are filled with stories about the opioid epidemic — the opioid crisis. Tens of thousands of Americans who die each year are found with opioids in …

This 45 minute video is a year old and has received 175,000 downloads. It is still current and very pertinent, as the HHS Task Force on Best Practices in Pain Management draws together its recommendations to Congress.

It’s wonderful to see that our story is reaching so many people. I just hope they’re not all other pain patients, but perhaps people that might never have seen this other “painful” side of the supposed “opioid crisis”. Continue reading

Doctors struggling with crackdown on prescriptions

Fox Part II I Doctors caught between struggling opioid patients and crackdown on prescriptions – By Elizabeth Llorente | Fox News

This is the second of a three-part series on the nation’s struggle to address its crippling opioid crisis, and the unintended victims left in its wake. Read Part 1 here: As doctors taper or end opioid prescriptions, many patients driven to despair, suicide.

Dr. Stephen Nadeau received a warning from the Gainesville, Fla., hospital where he worked. Their policy on prescribing opioids was changing, to go beyond federal guidelines aimed at the national overdose crisis that has claimed hundreds of thousands of lives.

The hospital would stop treating pain with opioids.  

That’s like a hospital deciding it would stop treating infections with antibiotics! Sure, not all people need them, but in some situations, it’s by far the best choice.    Continue reading

Dr. Darnall now supports necessary use of opioids

National Spotlight: Congressional Briefing, and Advocacy for Patient-Centered Research and Pain CareBeth Darnall, PhD – Oct 2018

This is significant because Dr. Darnall was the main proponent of the “catastrophizing is causing your pain” movement. This idea is exactly what the anti-opioid zealots needed to blame patients for their own pain.

This idea became so widespread that most of the public, and even far too many doctors, believed that changing patients’ “bad attitude” was the only treatment necessary for pain management.

Though I think it took far longer than it should have, Dr. Darnall now seems to have realized that her studies were grossly misinterpreted (and outright weaponized) to prove the preposterous idea that opioids are not necessary to treat chronic pain.

To her great credit, she is now fighting against the very misconceptions that her previous work encouraged.   Continue reading

Pain Experts Speak Out Against Forced Opioid Tapering

Pain Experts Speak Out Against Forced Opioid Tapering – Pain Medicine News – Dec 2018

The tone of this article is very pain-patient-centric and finally shows sympathy for our plight.

Appearing in a mainstream medical newsletter will give our cause far more visibility than what we publish on sites devoted to our cause, so I feel this is a positive sign that the media narrative is starting to shift.

I believe we’ll be seeing less of the outdated and outright wrong “innocent people getting hooked on prescription opioids” stories to more stories about Rx opioids denied to pain patients while others overdose on injected illicit opioids freely available on the black market.   Continue reading

Doctors Advocating for Pain Patients

While we’ve been thrown under the bus by most doctors, a few brave souls have been protesting since the unscientific and anti-opioid biased CDC Opioid Prescribing Guidelines were issued.

Each year, more doctors are speaking up and our medical professional advocates are publishing more and more studies poking holes in the guideline’s methodology and assumptions.

Below, I’ve listed these papers and articles in reverse chronological order so you can see the groundswell of opposition from medical experts (not self-appointed gurus) growing louder each year:   Continue reading

Opioids Effective for Peripheral and Neuropathic Pain

Oral opioid therapy for chronic peripheral and central neuropathic pain. – PubMed – NCBI – Pain Clinical Research Center, Department of Neurology, University of California, San Francisco, School of Medicine, San Francisco, USA – free full-text in N Engl J Med. – Mar 2003

This careful and rigorous study from 15 years ago showed clearly that an opioid, at least levorphanol, can be very effective for “central sensitization” types of pain.

I suspect the current doubts about opioid effectiveness for neuropathic pain are because they are afraid to use strong enough opioids in sufficient doses, because this article shows levorphanol IS effective.

Background:

Although opioids are commonly used to treat chronic neuropathic pain, there are limited data to guide their use. Few controlled trials have been performed, and many types of neuropathic pain remain unstudied.  Continue reading

Pain Experts Call for End to Forced Opioid Tapering

International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering | Pain Medicine | Oxford Academic – 29 November 2018

We, the undersigned, stand as a unified community of stakeholders and key opinion leaders deeply concerned about forced opioid tapering in patients receiving long-term prescription opioid therapy for chronic pain.

This is a large-scale humanitarian issue.

As happy as I am to see this declaration, even long after the opioid prescribing guidelines were weaponized to force opioid tapers, I’m appalled that it took 2.5 years of entirely foreseeable consequences for all these doctors to finally speak up.

There’s an impressively long list of signatories to this document, including several that have been vocally pushing for the very restrictions they now call a “large-scale humanitarian issue”. I’m stunned at the hypocrisy.   Continue reading

Opioids ARE effective versus placebo in chronic pain

Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials – Meske DS, Lawal OD, Elder H, Langberg V, Paillard F, Katz N – 19 December 2017

This is a study from almost a year ago that gives evidence that opioids ARE effective for our chronic pain. PROP manipulates the evidence to make it seem like opioids don’t work for us.

Introduction: To evaluate opioids’ efficacy in chronic non-cancer pain, we performed a meta-analysis of published clinical trials for μ-opioid receptor agonists performed for US Food and Drug Administration approval.

Methods: MEDLINE and Cochrane trial register were searched for enriched enrollment randomized withdrawal studies (before June 2016).   Continue reading

Opioid analgesic tolerance without hyperalgesia

Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release m… – PubMed – NCBI – Aug 2012

Although often successful in acute settings, long-term use of opioid pain medications may be accompanied by waning levels of analgesic response not readily attributable to advancing underlying disease, necessitating dose escalation to attain pain relief.

How can a doctor determine whether a patient’s increasing pain is attributable to “advancing underlying disease” or tolerance to opioids?

It’s impossible for anyone except the patient to determine this. Even for myself, it’s difficult to distinguish between increasing pain versus increasing tolerance to the medication.   Continue reading